context therapeutics inc is set to begin trading wednesday on the nasdaq capital market after its initial public offering priced to raise 25 million the womens oncology company late tuesday said the ipo of five million shares priced at 5 each in line with the reduced price projected monday which was down from an earlier estimate of 12 to 14 each the underwriter of the offering has a 45day option to buy up to an additional 750000 shares